COMPANY
Solaris Vaccines, Inc.
Funding and NIH signals
- NIH award NIH awarded $274K (STTR Phase I 5R41AI186746-02, continuation, notice Aug 14, 2026). NIH RePORTER 5R41AI186746-02 (Aug 14, 2026)
Evidence (1 event)
- Aug 14, 2026 · NIH RePORTER 5R41AI186746-02
Organization: SOLARIS VACCINES, INC.; City/State: FORT COLLINS, CO; Project number: 5R41AI186746-02; Activity code: R41; Fiscal year: 2026; Award notice date: 2026-08-14; FY total cost (award amount): 274002; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: A whole-cell inactivated vaccine for improved protection against tuberculosis; Organization type: Domestic For-Profits
- Aug 14, 2026 · NIH RePORTER 5R41AI186746-02
Timeline
- Grant Government grant — STTR: $274,002 (annual award, as published), announced Aug 14, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
- Grant Government grant — STTR: $269,874 (annual award, as published), announced Jul 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Grant Government contract — SBIR: $1.3M (total, as published), announced Jul 2, 2025. Agency: DoD. Source: government award database. source ↗
Funding
- Government grant — STTR: $274,002 (annual award, as published), announced Aug 14, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
- Government grant — STTR: $269,874 (annual award, as published), announced Jul 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
- Government contract — SBIR: $1.3M (total, as published), announced Jul 2, 2025. Agency: DoD. Source: government award database. source ↗
NIH awards 1
- NIH award 1R43AI172570-01A1 FY2023: $298,891 awarded for that fiscal year; activity R43 (SBIR); PI ARTINGER, MICHAEL; recipient as written: SOLARIS VACCINES, INC., FORT COLLINS, CO. Flu Vaccine Production Using a Nov source ↗